BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15843816)

  • 1. Maintained rules of development in a mouse B-cell tumor.
    Robbiani DF; Colon K; Affer M; Chesi M; Bergsagel PL
    Leukemia; 2005 Jul; 19(7):1278-80. PubMed ID: 15843816
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular mechanisms involved in human B and T cell neoplasia.
    Croce CM; Tsujimoto Y; Nowell PC
    Gene Amplif Anal; 1986; 4():143-60. PubMed ID: 3146545
    [No Abstract]   [Full Text] [Related]  

  • 3. Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination.
    Schlissel MS; Morrow T
    J Immunol; 1994 Aug; 153(4):1645-57. PubMed ID: 8046237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell populations during tumorigenesis in Eu-myc transgenic mice.
    Sidman CL; Shaffer DJ; Jacobsen K; Vargas SR; Osmond DG
    Leukemia; 1993 Jun; 7(6):887-95. PubMed ID: 8501983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assay.
    Yoshida M; Rybak RJ; Choi Y; Greenberg SJ; Barcos M; Kawata A; Matsuno F; Tsai H; Seon BK
    Cancer Res; 1997 Feb; 57(4):678-85. PubMed ID: 9044845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomorphic expression of Dkk1 in the doubleridge mouse: dose dependence and compensatory interactions with Lrp6.
    MacDonald BT; Adamska M; Meisler MH
    Development; 2004 Jun; 131(11):2543-52. PubMed ID: 15115753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin's lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction.
    Inghirami G; Szabolcs MJ; Yee HT; Corradini P; Cesarman E; Knowles DM
    Lab Invest; 1993 Jun; 68(6):746-57. PubMed ID: 8515660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study.
    McKeithan TW; Takimoto GS; Ohno H; Bjorling VS; Morgan R; Hecht BK; Dubé I; Sandberg AA; Rowley JD
    Genes Chromosomes Cancer; 1997 Sep; 20(1):64-72. PubMed ID: 9290956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of lymphocytes in interleukin 7-transgenic mice.
    Samaridis J; Casorati G; Traunecker A; Iglesias A; Gutierrez JC; Müller U; Palacios R
    Eur J Immunol; 1991 Feb; 21(2):453-60. PubMed ID: 1999226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular events in B lymphocyte differentiation. Inducible expression of the endogenous mouse mammary tumor proviral gene, Mtv-9.
    King LB; Lund FE; White DA; Sharma S; Corley RB
    J Immunol; 1990 Apr; 144(8):3218-27. PubMed ID: 2157765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic analysis of a potential Hoxd-11 limb regulatory element present in tetrapods and fish.
    Beckers J; Gérard M; Duboule D
    Dev Biol; 1996 Dec; 180(2):543-53. PubMed ID: 8954726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of regulatory mechanism for humoral immunity using transgenic mice of rearranged immunoglobulin genes].
    Shimizu A
    Tanpakushitsu Kakusan Koso; 1995 Oct; 40(14):2107-17. PubMed ID: 8532866
    [No Abstract]   [Full Text] [Related]  

  • 13. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
    Roland J; Morello D
    Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants.
    Wagner KU; Dierisseau P; Rucker EB; Robinson GW; Hennighausen L
    Oncogene; 1998 Nov; 17(21):2761-70. PubMed ID: 9840940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Bcd, a novel proto-oncogene expressed in B-cells.
    El Rouby S; Newcomb EW
    Oncogene; 1996 Dec; 13(12):2623-30. PubMed ID: 9000136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate developmental expression of human CD8 beta in transgenic mice.
    Kieffer LJ; Yan L; Hanke JH; Kavathas PB
    J Immunol; 1997 Nov; 159(10):4907-12. PubMed ID: 9366416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gamma delta T cells--gene to biology].
    Itohara S
    Tanpakushitsu Kakusan Koso; 1995 Oct; 40(14):2118-25. PubMed ID: 8532867
    [No Abstract]   [Full Text] [Related]  

  • 18. ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review.
    Kim MJ; Yoon HS; Lim G; Kim SY; Lee HJ; Suh JT; Lee J; Lee WI; Park TS
    Cancer Genet Cytogenet; 2010 Jan; 196(2):184-8. PubMed ID: 20082857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex PCR and Genescan analysis to detect immunoglobulin heavy chain gene rearrangement in feline B-cell neoplasms.
    Mochizuki H; Nakamura K; Sato H; Goto-Koshino Y; Sato M; Takahashi M; Fujino Y; Ohno K; Uchida K; Nakayama H; Tsujimoto H
    Vet Immunol Immunopathol; 2011 Sep; 143(1-2):38-45. PubMed ID: 21703693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The murine VpreB1 and VpreB2 genes both encode a protein of the surrogate light chain and are co-expressed during B cell development.
    Dul JL; Argon Y; Winkler T; ten Boekel E; Melchers F; Mårtensson IL
    Eur J Immunol; 1996 Apr; 26(4):906-13. PubMed ID: 8625987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.